Company Quick10K Filing
Cigna
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$147.45 244 $35,909
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2018-12-20 M&A, Off-BS Arrangement, Shareholder Rights, Control, Officers, Amend Bylaw, Other Events, Exhibits
8-K 2018-12-18 Regulation FD
8-K 2018-12-13 Regulation FD
8-K 2018-11-21 Regulation FD
8-K 2018-11-21 Enter Agreement, Regulation FD, Exhibits
8-K 2018-11-01 Earnings, Exhibits
8-K 2018-09-23 Officers, Other Events, Exhibits
8-K 2018-09-17 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-09-17 Other Events, Exhibits
8-K 2018-09-11 Regulation FD
8-K 2018-09-04 Regulation FD, Exhibits
8-K 2018-08-29 Regulation FD
8-K 2018-08-24 Shareholder Vote, Other Events, Exhibits
8-K 2018-08-21 Regulation FD
8-K 2018-08-13 Other Events, Exhibits
8-K 2018-08-10 Other Events, Exhibits
8-K 2018-08-09 Other Events, Exhibits
8-K 2018-08-08 Other Events
8-K 2018-08-07 Other Events, Exhibits
8-K 2018-08-02 Earnings, Exhibits
8-K 2018-06-27 Enter Agreement, Officers
8-K 2018-05-31 Regulation FD
8-K 2018-04-25 Amend Bylaw, Shareholder Vote
8-K 2018-04-23 Other Events
8-K 2018-04-06 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-03-12 Officers
8-K 2018-03-08 Other Events, Exhibits
8-K 2018-02-27 Regulation FD
8-K 2018-02-01 Earnings, Exhibits
8-K 2018-01-09 Earnings, Regulation FD

Cigna Financials

-

CI Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Quarter)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Anthem (ANTM) 73,881 75,851 45,058 96,756 25,368 4,074 6,420 88,089
Humana (HUM) 35,565 28,913 17,041 60,726 0 2,505 4,075 35,164
Cigna (CI) 49,820 82,956 67,371 44,845 0 2,766 4,617 50,829
Centene (CNC) 21,833 34,368 22,098 69,541 67,197 1,277 2,854 21,332
Laboratory of America (LH) 16,943 17,744 10,580 11,292 3,177 854 2,348 22,813
Quest Diagnostics (DGX) 13,740 11,760 6,301 7,572 2,606 781 1,489 17,443
Wellcare Health Plans (WCG) 14,540 13,206 8,602 24,901 19,250 521 1,110 13,453
Henry Schein (HSIC) 10,372 7,112 3,378 11,463 3,318 500 989 11,269
Guardant Health (GH) 7,812 940 78 145 0 -81 -74 7,637
Molina Healthcare (MOH) 9,201 6,690 4,954 17,673 664 792 1,222 8,191
Genomic Health (GHDX) 2,068 426 109 105 89 50 64 1,824
Acadia Healthcare Company (ACHC) 3,015 6,790 4,336 3,054 0 -208 -28 6,218
Natera (NTRA) 1,892 383 290 273 108 -128 -107 1,935
Invitae (NVTA) 503 161 177 69 -148 -130 -178
Patterson Companies (PDCO) 1,786 3,350 1,846 4,130 1,197 118 190 2,420
Biotelemetry (BEAT) 1,823 664 317 419 262 46 101 1,968
Veracyte (VCYT) 1,282 252 28 109 75 0 5 1,089
Caredx (CDNA) 1,467 143 50 102 20 -39 -36 1,423
Trupanion (TRUP) 1,211 230 99 340 58 0 7 1,202
Radnet (RDNT) 763 1,597 1,384 1,035 104 43 122 1,405

Balance Sheet ($MM)2012-03-312012-06-302012-09-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash2,1113,0452,2363,3063,2093,0552,7952,2761,9671,6211,4202,6201,9692,3811,9682,4012,4543,2243,1854,1553,6113,6562,9722,7713,63424,032
Accounts Receivable1,019911898
Inventory
PP&E1,0831,1151,1361,1091,1911,4513,6891,4501,4981,4943,9311,4861,5021,4834,0161,5341,5561,5614,3641,5191,5091,5264,6131,5521,5541,559
Assets52,78553,55353,53154,93953,82954,04354,33655,17355,92955,65355,89658,12257,13256,90957,08858,88459,50660,76259,36061,14761,73861,93661,75363,14163,10282,956
Accounts Payable
Long-Term Debt
Liabilities44,22444,53144,00145,16643,95344,07443,65944,50844,87844,38545,01747,08145,75345,05544,97546,12746,07146,71245,57546,86247,13347,73947,96948,89748,32067,371
Stockholders' Equity8,5619,0229,5309,6609,7759,87410,56710,55610,93711,15710,77410,94211,29011,77412,03512,67513,35613,97413,72314,22614,54614,14513,73514,19514,74315,555
Income Statement ($MM)2012-03-312012-06-302012-09-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue6,7887,4577,3588,1837,9808,0668,1518,4969,1638,7578,9289,4679,4929,3899,5289,8849,9609,8809,94410,38510,82310,38210,53111,38011,47711,457
Cost of Revenue
Gross Profit
R&D
SG&A
Tax18120825215261246230324471332239323352334241305310290231297324262224301488259
Net Income37138046659506553360529572531462531584544418514503452374593810562267917808774
Cash Flow ($MM)2012-03-312012-06-302012-09-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating941936-320-8055752,025995624
Cash Investing-3,419-4-441962185-603-1,700-99125
Cash Financing-10614-58185-339-683-530-1219,657